Response against single minor histocompatibility antigens. I. Functional and immunogenetic analysis of cloned cytolytic T cells

A clonal approach was used to investigate the cellular basis of a T cell response to single minor histocompatibility antigens (miHA). This analysis was performed by functional and immunogenetic characterization of a large number of clones derived from short-term mixed leukocyte culture (MLC) populations generated against the miHA, H-1.3. Forty-nine clones isolated from such MLC were specifically cytolytic for H-1.3-bearing, H-2Db-compatible target cells. Thirty-seven of the 49 cytolytic clones were driven to proliferate when stimulated by spleen cells bearing the H-1.3 alloantigen in the absence of added T cell-derived growth factor(s) (GF). The remaining 12 clones proliferated only when GF was added. A strong positive correlation was observed between antigen-induced proliferation and the production of interleukin 2 (IL 2) activity. A similar correlation was observed when comparing the ability of both antigen and concanavalin A to induce IL 2 activity from the clones. These data suggest that i) antigen-driven or helper T cell-independent cytolytic T cells (HITc) are frequent components of an MLC response to a single miHA, and ii) the ability of HITc to undergo antigen-driven proliferation is related to their ability to produce antigen-induced GF.

Role of the H-2 complex in the induction of T cell tolerance to self minor histocompatibility antigens

The present study has utilized cytotoxic T lymphocyte (CTL) responses specific for minor histocompatibility (minor H) antigens as an experimental approach to determining whether recognition of self MHC determinants is involved in the induction of T cell tolerance to self antigens. It was observed that C3H.SW splenic T cells from C3H.SW leads to B10 X B10.BR radiation bone marrow chimeras contained CTL precursors (pCTL) reactive against self C3H minor H antigens + H-2k but were tolerant to self C3H minor H antigens + H-2b. Precursor CTL with the reciprocal reactivity pattern were observed for C3H leads to B10 X B10.BR chimeras. In addition, it was observed that C3H.SW thymocytes from C3H.SW leads to B10 X B10.BR chimeras could generate minor H-specific CTL responses and were reactive against self C3H minor H antigens + H-2k, but were tolerant to self C3H minor H antigens + H-2b. Thus, the present study demonstrates that for peripheral and intrathymic T cell populations at least a component of T cell tolerance to self antigens is restricted by products of the MHC.

Prevention of lethal, minor-determinate graft-host disease in mice by the in vivo administration of anti-asialo GM1

Graft-vs-Host disease (GVHD) remains a devastating problem in human bone marrow transplantation (1, 2). Because removal of Thy-bearing cells from the donor inoculum has prevented GVHD in murine models (3, 4), it has been hoped that a similar cell surface antigen or combination of antigens could be found in humans. Unfortunately, treatment of human donor cells with various T cell antisera has not yet been successful in preventing GVHD (5). Encouraging results have been reported in five patients who received bone marrow depleted of T cells by the sequential use of soybean agglutinin and the differential sedimentation of cells forming rosettes with sheep red blood cells (6). Although donor T cells are thought to be necessary for initiating GVHD, the immunopathogenesis of GVHD is still not understood. Because donors and recipients are routinely major histocompatibility complex matched and chosen to be nonreactive in mixed lymphocyte cultures human GVHD is thought to result from minor histocompatibility antigen disparities. Lopez and coworkers (7, 8) found a strong association between the incidence of human GVHD and the pretransplant levels of natural killer (NK) activity of the recipients; when the recipient NK activity was low, GVHD rarely developed. They speculated that the NK cell lineage is serving as an important stimulator-inducer. We therefore examined the in vivo effects of anti-asialo GM1 on a murine model of GVHD based on minor antigen disparity. This antiserum has several immunologic effects, including a profound NK suppression. We found that the mice treated with this antibody have normal survival rates, even though they do develop histologic GVHD in the skin. This finding suggests the possibility of a new prophylactic approach to human GVHD and raises many questions regarding the function of asialo GM1-bearing cells in immune regulation.

Genetic control and effector cells in host-versus-graft responses to H-Y antigen in mice

T cell responses to the male-specific H-Y antigen in mice include skin graft rejection, delayed-type hypersensitivity and cytotoxic T cell responses; these are under complex H-2 and non-H-2 Ir gene control. The effector cells for these two in vivo responses are Ly 1+2-, and the cytotoxic T cell effectors generated in secondary mixed lymphocyte reactions in vitro are Ly1+2+, although their development requires the presence of Ly 1+2- T helper cells. We investigated the Ir gene control of another in vivo response to H-Y, the host-versus-graft response (HVGR), measured by popliteal lymph node enlargement. The strain distribution pattern (SDP) of primary and secondary HVG responses to H-Y indicates that there are both H-2 and non-H-2 Ir genes involved in controlling responsiveness. Cell transfer of the secondary response identifies an Ly 1+2- effector T cell for this response: this information together with the SDP of cytotoxic T cell responses suggests that the HVGR may represent activation of the T helper population involved in the generation of cytotoxic T cells.

Alloimmunization-activated suppressor cells. II. In vitro activity of suppressor cells implicated in the abrogation of lethal graft-versus-host reaction

Incompatibility for DBA/2 (D2) minor histocompatibility antigens (MiHA) alone leads to a severe lethal graft-versus-host reaction (GVHR) in irradiated (D2 X B10.D2)F1 mice receiving a bone-marrow-plus-spleen-cell graft from B10.D2 donors. This mortality is abrogated when the donors are preimmunized simultaneously against specific D2 MiHA and unrelated H-2 antigens three days before grafting. Results presented here demonstrate that spleen cells from such preimmunized donors, which are able to diminish the intensity of the GVHR developed by normal cells, exhibit the following properties: (1) reduced proliferative response to D2 MiHA in one-way MLC; (2) radioresistant suppressive effect on the proliferative responses of both normal and specifically primed B10.D2 cells; (3) inability to lyse D2 target cells even after in vitro boosting, implying that the suppressive effect detected in vitro is not due to removal of the stimulating antigens from the culture; and (4) inability to suppress the development of an anti-MiHA cytolytic response by specifically primed B10.D2 cells, despite a pronounced suppressive effect on their proliferation. Taken together with the GVHR observations, these results suggest that simultaneous immunization against specific MiHA and unrelated H-2 antigens activates, in the spleens of treated donors, suppressor cells that can inhibit the immune response at the recognition phase, and probably also at an afferent, but not efferent, stage of cytotoxic effector-cell differentiation.

Activation of helper T cells for B lymphocytes in primary mixed lymphocyte cultures

Normal B10.BR (H-2k, C57B1/6 background) spleen cells, enriched in primary mixed lymphocyte culture (MLC) for antigens of C3H/Tif mice (H-2k, C3H background), induced normal C3H/Tif but not B10.BR B lymphocytes to proliferate and produce Ig. In contrast, normal B10.BR spleen cells enriched in parallel B10.BR anti-C57B1/6 (H-2b) MLC were not able to activate either B10.BR or C57B1/6 B lymphocytes. However, normal B10.BR spleen cells depleted of Lyt2+ cells before initiation of the MLC, and subsequently enriched either for C3H/Tif or C57B1/6 antigens, activated B lymphocytes of the respective mouse strains specifically and equally well. These experiments show that primary MLC gives rise to effector T helper cells that, on recognition of specific alloantigens, activate normal B lymphocytes of the 'stimulator' strain. In response to major histocompatibility complex (MHC) alloantigens, this help is not revealed because of interference by Lyt 2+ lymphocytes. MHC-reactive T helper cells for B lymphocytes, however, participate in these reactions and constitute the predominant population in long-term cultures that are maintained by consecutive in vitro restimulations.

Prolongation of skin graft survival across different genetic barriers in rats with cyclosporine--and its potentiation by Bordetella pertussis vaccine

Skin allografting was performed in rats treated with cyclosporine using strain combinations that differed across the RT1.A (class I) or RT1.B (class II) loci of the major histocompatibility complex (MHC) or across non-MHC loci. Injection of cyclosporine (20 mg/kg) for 14 consecutive days was followed by prolonged acceptance (MST = 67 days) of the skin allografts. Bordetella pertussis vaccine potentiated the effect of cyclosporine, and the synergistic effect of the vaccine occurred only when it was given before grafting. The cyclosporine given for 14 days with or without B pertussis failed to prolong second-set skin grafts. Production of hemagglutinating antibodies in cyclosporine-treated animals was completely suppressed when the skin grafts were in place, and it occurred to a much lesser extent following rejection, as compared with untreated animals. The cyclosporine did not, however, influence the antibody response following second set skin graft rejection. A system in which rats were treated for only 6 days with cyclosporine was developed in order to test the effects of disparities at different histocompatibility loci on the response to cyclosporine, because this regimen gave a marginal, but significant, prolongation of skin grafts across a full RT1 (MHC) difference. There was a differential effect of cyclosporine treatment depending upon the genetic differences involved: a skin graft across an RT1.A (class I) difference was indefinitely prolonged, one across an RT1.B (class II) or RT1.AB difference was slightly prolonged (9 to 12 days and 12.5 to 16.5 days, respectively) and a graft across non-MHC differences was not affected. Hence, the immunosuppressive effects of cyclosporine on skin graft rejection appear to depend upon the genetic disparities between donor and recipient. Exploitation of this finding may lead to the design of more effective, multidrug protocols for the treatment of rejection that would have fewer deleterious side-effects.

T cell tolerance to non-H-2-encoded stimulatory alloantigens is induced intrathymically but not prethymically

The present report has evaluated the differentiation compartment in which T cells are tolerized to non-major histocompatibility complex (MHC)-encoded minor lymphocyte-stimulating locus (MLS) alloantigens. It was observed that T cell precursors are not tolerized prethymically to MLS alloantigens but are tolerized intrathymically and postthymically to MLS alloantigens. The failure of prethymic T cells to be tolerized indicates either that T cell precursors are unable to be tolerized to MLS alloantigens or that cells in the prethymic compartment are unable to induce MLS-specific tolerance. In either case, these results demonstrate that the thymus is the initial site in which T cell tolerance to MLS alloantigen is induced. The present results also demonstrate a striking disparity in the reactivity of thymocytes to MHC and MLS alloantigens expressed in the extrathymic host through which their precursors had migrated. In the experimental mice constructed for these studies, intrathymic T cells were tolerant to the MHC alloantigens but were reactive to the MLS alloantigens expressed by the extrathymic host. This observation is consistent with the concept that T cell precursors may be tolerized to MHC alloantigens at an earlier point in their differentiation than they are tolerized to non-MHC-encoded MLS alloantigens.

Secondary delayed-type hypersensitivity to sheep red blood cells and minor histocompatibility antigens in mice: transfer of memory by recirculating thoracic duct lymphocytes

Secondary delayed-type hypersensitivity (DTH) in mice to sheep red blood cells (SRBC) and minor histocompatibility (H) antigens is dependent on long-lived memory T cells. In this paper we investigated whether these memory T cells recirculate. It was shown that late phase "immune' thoracic duct lymphocytes (TDL) from mice which were immunized with SRBC or non-H-2-incompatible spleen cells several weeks previously could adoptively transfer secondary DTH to these antigens. Passing the immune TDL through intermediate recipients demonstrated that these SRBC- or minor H-antigen-reactive memory T cells recirculate from blood to lymph. In contrast to mice immunized with minor H antigens, no secondary type DTH reactivity could be demonstrated in mice immunized with H-2-incompatible spleen cells. Also, after adoptive transfer of TDL from mice immunized with H-2-alloantigens, it was impossible to demonstrate an accelerated DTH reactivity.

Acute and chronic graft-versus-host disease induced by minor histocompatibility antigens in mice

We have developed a murine model of acute and chronic forms of graft-versus-host disease (GVHD) as defined by clinical features that develop in response to minor histocompatibility antigen (minor HA) differences. C57BL/6J (B6) and LP/J mice were selected for serologic identity at H-2 and for mutual nonreactivity in mixed lymphocyte culture (MLC). Lethally irradiated B6 recipients were transplanted with anti-Thy-1.2-treated LP bone marrow cells plus various numbers of untreated LP spleen cells. The B6 recipient mice developed acute and chronic forms of GVHD that showed clinical and histological similarities to the acute and chronic forms of GVHD seen in human recipients of bone marrow transplants from HLA-identical and MLC-nonreactive donors. The definition of acute and chronic GVHD by clinical criteria appears to have biological significance in predicting subsequent survival patterns of recipient mice with GVHD. The incidence of acute and chronic GVHD in the mouse model was a function of the number of donor spleen cells transplanted. Using this model, we demonstrate that both acute and chronic forms of GVHD are initiated by donor lymphocytes. Based on these results, acute and chronic forms of GVHD induced to minor HA appear to be two manifestations of the same T-cell-mediated disease process rather than two different diseases.

Response to skin grafts exchanged among siblings of larval and adult gynogenetic diploids in Xenopus laevis

Gynogenetic diploid individuals were produced in an anuran amphibian, Xenopus laevis, and their response to skin grafts exchanged among siblings was studied. All skin grafts exchanged among nongynogenetic sibling froglets, as well as those from genetically unrelated donors, were rejected within 30 days. More than half (57%) of the gynogens that received grafts from sibling partners exhibited a prolonged survival (over 30 days), including long-term survival of over 120 days in 13%. The skin grafted from genetically unrelated froglets onto Nieuwkoop and Faber stage 42-56 larvae and onto perimetamorphic stage 58-65 animals was rejected within 30 days. Similarly, most (96%) of the skin grafts from outbred sibling froglets onto larvae at these stages were rejected acutely or subacutely (12-39 days). However, the skin grafted from sibling froglets to gynogens at larval stage 42-56 and perimetamorphic stage 58-61 enjoyed a long-term survival significantly more frequently (81%) than that in the final metamorphic (stage 64-65) counterparts (57%). These results support the view that in the adult Xenopus allograft responses are reactions to a single MHC as well as to cumulative, multiple minor H-locus barriers. The results also suggest that in larval stages the responses against minor H-locus barriers are generated only mildly.

Possible roles of compound membrane receptors in the immune system

A compound receptor is defined as a molecular complex which attains its final, biologically active structure by rearrangement and assembly in the membrane of several structural subunits. The existence of such receptor complexes is strongly suggested by experiments which demonstrated a very close association between certain ligand (primarily insulin) receptors and the major histocompatibility complex (MHC) antigens. We present here speculations on the possible role of MHC as a structural part of a multitude of receptors with different biological functions, and we argue that recent immunological data on minor histocompatibility antigens, antigen-presenting cells and T-lymphocyte receptors fit into this hypothesis.

Selection of the T-cell repertoire during ontogeny

This report examines conflicting hypotheses concerning T-cell repertoire selection in terms of H-2 restriction during ontogeny. The experiments described in this report were incompatible with the hypothesis that bias in the repertoire is solely a consequence of "more or less intentional priming" by foreign antigen. Rather, results indicate that the repertoire is selected by self major histocompatibility complex (MHC) antigens in the absence of foreign antigens. Allorestricted T cells, the existence of which was previously thought to be incompatible with the concept of complete repertoire selection by self MHC antigens, were shown to significantly cross-react on targets expressing self MHC antigens. Thus, it is possible that allorestricted T cells are simply cross-reactive T-cell clones restricted by self MHC antigens; indeed, all experimental data were compatible with the idea of complete selection of the T-cell repertoire in terms of H-2 restriction by self MHC antigens.

The use of cytotoxic T cell lines to detect the segregation of a human minor alloantigen within families

A cytotoxic T cell (CTL) line, which detected a minor alloantigen provisionally called W was generated in vitro with lymphocytes from a multiply transfused individual, S1. Lymphocytes from S1 were first stimulated with cells from an unrelated known from previous studies to express the minor antigen. The primary CTL were then restimulated with cells from a W +/ve HLA identical sib, S2, in the presence of IL-2. As in previous work, recognition of the W antigen by these CTL was restricted by HLA-B7. Antigen assignments of W + W -, based upon cold target inhibition studies, confirmed previous assignments which had depended upon the ability of lymphocytes either to stimulate the generation of or to be killed by anti-W CTL effectors. Testing of lymphocyte targets from members of several unrelated families in which HLA-B7 segregated showed that the CTL lines could detect the expression of W on cells of individuals in the general population. In 3 of 5 cases, members of an HLA identical sib pair differed for W. These results open up the possibility of designing studies using CTL lines to determine whether differences for minor alloantigens play a role in clinical transplantation.

The relative roles of MHC and non-MHC genes in heart and skin allograft survival

Although the role of the major histocompatibility complex (MHC) of the rat (RT1) in graft rejection has been established, the role of non-RT1 genes is not well understood. To investigate the influence of MHC and non-MHC genes in graft rejection, various combinations of congenic and inbred strains of rats were used as donors and recipients of skin grafts and perfused abdominal heart grafts. In addition, hemagglutinating and cytotoxic antibody responses were evaluated to assess loci that were serologically active in transplantation. Our results demonstrate that: (1) RT1 antigens are the most important determinant in heart and skin rejection; (2) antigens controlled by non-MHC genes also play a major role in rejection because they cause disparate heart grafts to be rejected by day 18 and skin grafts by day 26; (3) RT2 cell antigens alone do not cause graft rejection; and (4) allogeneic differences at the RT1, RT2, RT3, and RT6 loci elicit an antibody response in heart transplantation.

Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens

Incompatibility for DBA/2 (D2) minor histocompatibility antigens (MiHA) alone leads to a severe lethal graft-versus-host reaction (GVHR) in adult (D2 X B10.D2)F1 recipients of B10.D2 bone marrow and spleen cells. In this genetic combination, mortality is completely abrogated by preimmunization of the graft donor against unrelated H-2b antigens and specific D2 MiHA a short time before grafting. Protection against GVHR mortality is elicited by immunizing the donors with a single transfusion of incompatible spleen cells or whole blood. Abrogation of GVHR mortality is due mainly to the immunization with specific MiHA, and only to a much lesser degree to the immunization with unrelated H-2 antigens; the protective effect induced by association of these two types of immunization, however, is significantly better than that elicited by either type of immunization alone. It is unlikely that this abrogation of GVHR mortality results from "dilution" of specifically reactive cells; rather, suppressor cells appear to be a contributing factor, because the preimmunization activates, in the donor spleen, suppressor cells capable of decreasing the severity of the GVHR developed against MiHA by normal cells. Histopathologic observations indicated that the lesions induced in various tissues after grafting of preimmunized donor cells were considerably less severe than those induced by grafting of normal donor cells. However, simultaneous immunization with specific MiHA and unrelated H-2 antigens may also exacerbate the GVHR, depending upon the conditions used for preimmunization; abrogation of GVHR mortality is favored by a single immunization with unrelated H-2b antigens and specific MiHA administered simultaneously a short time before grafting, whereas an acceleration of GVHR mortality is favored by long intervals and multiple immunizations. It is suggested that, depending upon the conditions used for the preimmunization, the allogeneic effect produced by stimulation with unrelated H-2 antigens may augment the response to MiHA or it may enhance the activation of suppressor cells that contribute to the abrogation of GVHR mortality.

Rous sarcoma virus-induced tumours in mice. II. Contribution of H-2 and non-H-2 alloantigen barriers to tumour immunogenicity in vivo

The features of the immune recognition of a murine fibrosarcoma induced by Rous sarcoma virus were tested in histocompatible and histoincompatible mice. No evidence of a genetic regulation of spontaneous reactivity to tumour-associated antigens was found in various histocompatible F1 hybrids. Incompatibility in multiple minor histocompatibility antigens triggers a host reaction incapable of causing tumour rejection in some cases. The growth rate of incipient tumours is unaffected, whereas that of already visible tumour masses is significantly delayed. Admixture to the challenge of inactivated leukocytes bearing the same minor histocompatibility antigens as the tumour triggers a significantly stronger reaction. The reaction of hosts incompatible in the H-2K or H-2DL regions is quite efficient. However, the intensity of the immune reaction of H-2DLs antigens displayed by tumour cells is markedly dependent on the alleles of genes located in the central regions of the H-2 complex.

Complexity of the histocompatibility-3 region in the mouse

Congenic lines C57BL/10Sn (H-3a), B10.LP-H-3b, B10.C-H-3c, and B10.KR-H-3d were arranged into the 12 possible recipient-donor combinations and immunized. The spleen cells of each recipient were then tested for the presence of cytolytic effector T lymphocytes (CTL) specific for antigenic determinants controlled by the H-3 locus and restricted by class I H-2 loci. The strain-distribution pattern of the determinants defined by the individual CTL was determined by direct testing and by cold-target inhibition analysis. The restriction elements of the individual determinants were identified by the testing of H-2 recombinant strains and by antibody blocking. Five determinants were identified: 1 and 2, restricted by the Db molecule; 3 and 4 restricted by the Kb molecule; and 5, for which the restriction molecule could not be determined. The distribution pattern of determinants 3 and 4 correlated with the distribution of alleles at the beta 2-microglobulin locus. The data could be interpreted as arguing for the existence of three loci in the H-3 complex, with one coding for mutually antithetical determinants 1 and 2, another coding for mutually antithetical determinants 3 and 4, and still another coding for determinant 5.

Regulation of cytotoxic reactivity to minor histocompatibility antigens by administration of Corynebacterium parvum

B10.BR(H-2k) mice were primed with H-2-identical allogeneic CBA/J(H-2k) spleen cells and restimulated in vitro 14 days later to generate specific secondary cytotoxic lymphocytes. A single intravenous injection of primed mice with 700 micrograms of Corynebacterium parvum 7 days after alloimmunization markedly inhibited the subsequent secondary in vitro generation of cytotoxic cells. In addition, regulatory spleen cells were detected in alloimmunized C-parvum-injected mice that prevented the restimulation of primed control spleen cells. Suppressive activity could not be abrogated by treating regulatory cells with anti-theta antibody and complement or by removing phagocytic cells, but it was overcome by treatment with mitomycin C. Unfractionated regulatory cells suppressed responses in an antigen nonspecific fashion. However, cells remaining after carbonyl and iron treatment (nonphagocytic) could no longer suppress responses to third party alloantigens while maintaining significant suppression of anti-CBA responses. These data suggest the generation of two distinct suppressor cell types that can control the cytotoxic response to minor histocompatibility antigens: an antigen-nonspecific phagocytic cell and an antigen specific nonphagocytic, non-theta-bearing cell.

Lethal GVHD across minor histocompatibility barriers: nature of the effector cells and role of the H-2 complex

Transfer of T-cells to heavily irradiated, H-2-compatible mice frequently leads to a high incidence of lethal graft-versus-host disease (GVHD). Lymphoid cells depleted of Thy1+ cells fail to cause GVHD. Studies with a variety of different, H-2-compatible, strain-combinations suggest that minor, histocompatibility antigens (minor HA) are the main targets for eliciting lethal GVHD. Experiments in which T-cells are negatively selected to minor HA by acute blood-to-lymph recirculation through irradiated hosts have indicated that the T-cells eliciting GVHD to minor HA, are H-2-restricted. In H-2-compatible hosts, the donor T-cells recognize the minor HA of the host and become temporarily trapped in the lymphoid tissues for 1-2 days; during this stage of negative selection, the donor T-cells entering the lymph are specifically devoid of cells able to elicit GVHD against the host, minor HA on further transfer. When the selection host is H-2-different with respect to the donor T-cells, by contrast, the T-cells ignore the host, minor HA and negative selection fails to occur. The T-cells recirculate normally and are unimpaired in their capacity to elicit GVHD on further transfer. By the use of various H-2-recombinant mice as selection hosts it has been shown that, as for T-cells exerting cell-mediated lympholysis (CML) to minor HA in vitro, the T-cells which elicit lethal GVHD to minor HA comprise two distinct subsets of H-2-restricted cells. One subset recognizes minor HA in the context of H-2K (or K end) molecules whereas the other is specific for minor HA-plus-H-2D. Curiously, in marked contrast to the findings on CML responses in vitro, no evidence has been found that H-2I-restricted T-cells contribute to GVHD, either as effector cells or as helper cells. Purified populations of Lyt 1-2+ T-cells have potent GVHD activity, whereas Lyt 1+2- cells fail to cause GVHD. Studies with various types of bone-marrow chimeras suggest that in the induction phase, T-cells recognize minor HA only on lymphohematopoietic cells. In the effector phase, by contrast, non-marrow-derived cells appear to be the main targets of attack. Although the pathogenesis of GVHD is poorly understood, the lethal form of the disease probably reflects the penetration of mucosal surfaces by pathogenic organisms, perhaps as the result of direct destruction of epithelial cells by minor HA-specific cytotoxic lymphocytes. Direct support for this notion has yet to be obtained.

Microfingerprinting analysis of human Ia molecules favours a three loci model

Alpha subunits from DC1 Ia molecules, when compared with DR alpha subunits, are shown to possess distinctive features revealed by differences in microfingerprinting patterns after peptic digestion. Alpha chains from BR4X7 molecules differ from DC1 alpha chains and are more similar to DR alpha chains. Since DC1 and BR4X7 beta chains (which carry the HLA-controlled alloantigenic determinants) associate with different alpha subunits, it is considered unlikely that they are controlled by alleles at the same locus. The proposed model implies the existence of three tightly linked HLA loci controlling the beta subunits of DR, DC and BR molecules respectively.

Helper cell-independent cytolytic T lymphocytes specific for a minor histocompatibility antigen

We have isolated several anti-H-2Db-restricted cytolytic T cell clones specific for the minor histocompatibility antigen, H-1, from a long-term B10.129(5M) anti-C57BL/6 mixed leukocyte culture. All proliferate significantly, in the absence of exogenously added lymphokine, and in a specific manner to H-2Db-compatible stimulator cells that carry the appropriate H-1 minor antigen. Moreover, significant proliferation also occurs when T cell-depleted stimulator cells are used as the antigenic stimulus, indicating that the proliferative capacity of these clones is not the result of T cell factors produced by the stimulator cells. After concanavalin A stimulation, IL 2-like lymphokine activity can be detected from the one clone tested, 5M/B6-5. These data demonstrate the existence of antigen-driven, helper T cell-independent cytolytic T cell clones responsive to a single minor histocompatibility antigen. The implications of this finding are discussed.

In vivo development of cytolytic T lymphocytes (CTL) to hapten-altered self: MIs-disparate cells facilitate the response by neutralizing IL 2 inhibitor

Inability to develop CTL in vivo to hapten-altered self can be attributed in part to an inhibitor of interleukin 2 (IL 2) that is present in the serum of normal mice. We have shown earlier that hapten-specific CTL can be generated in C3H mice (H-2k, MIsc) provided CBA/J (H-2k MIsd) spleen cells are injected simultaneously with hapten-modified syngeneic spleen cells into the hind foot paws. In efforts to determine whether serum levels of the inhibitor of IL 2 are altered as a consequence of this successful immunization method, we have compared the activity of the inhibitor in serum at intervals after the injection of syngeneic spleen cells, CBA spleen cells, or TNP-C3H spleen cells alone or together with CBA spleen cells, by using a murine IL 2-dependent, cloned cytotoxic T cell line, CT-6. The results indicate that inhibitor was neutralized optimally 48 to 72 hr after injection of TNP-C3H spleen cells mixed with CBA/J spleen cells. The order in which neutralization occurred was as follows: TNP-C3H cells + CBA/J cells greater than CBA cells greater than TNP-C3H cells greater than normal C3H spleen cells. Furthermore, supernatants from cultures of C3H lymph node cells stimulated in vivo with CBA/J cells also contained IL 2 activity. Thus, injection of CBA/J cells with TNP-modified syngeneic spleen cells produces IL 2 in vivo in sufficient quantity to neutralize the activity of the inhibitor as well as to facilitate the maturation of pre-CTL into hapten-altered self-specific CTL.